drug

(probenecid + sulopenem etzadroxil)

Marketedupdated 2mo ago

by $ITRMF Iterum Therapeutics plc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Patent cliff

source: FDA Orange Book

first barrier falls

Jun 3, 2029

~2.9 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (5)

Dec 23, 2039formulationUS 11478428
Dec 23, 2039formulationUS 12544337
Apr 1, 2039method-of-use (U-4026)US 11554112
Apr 1, 2039method-of-use (U-4026)US 12109197
Jun 3, 2029compositionUS 77952432.9y

FDA exclusivities (2)

Oct 25, 2034GAINGAIN Antibiotic (5y)
Oct 25, 2029NCENew Chemical Entity (5y)3.3y

Data sources

ClinicalTrials.gov

last refreshed 53m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 3